Update on the Prevention and Control of Healthcare Associated Infections in the Betsi Cadwaladr University Health Board

Size: px
Start display at page:

Download "Update on the Prevention and Control of Healthcare Associated Infections in the Betsi Cadwaladr University Health Board"

Transcription

1 Betsi Cadwaladr University Health Board Health Board Meeting Date: 23 rd January 2014 Item 14/007 Subject: Update on the Prevention and Control of Healthcare Associated Infections in the Betsi Cadwaladr University Health Board Summary or Issues of Significance The Health Board remains determined to do everything possible to reduce infections to the minimum. This paper provides the Board with: An update on progress with infection prevention, including progress in reducing Clostridium difficile infection, the prevention of MRSA, and the actions in place to strengthen Norovirus control measures. A detailed briefing on the work programme to improve antimicrobial prescribing across BCUHB, and the actions necessary to achieve required outcomes. A briefing on the new Welsh Government healthcareassociated infection reduction targets. Strategic Theme / Priority / Values / Francis Report recommendations addressed by this paper Making it safe / better / sound / work / happen? Making it safe Making it better Making it sound Making it happen Relevant legislation or Standard for Health Services: Evidence base or other relevant information to inform decision (e.g risk assessment, consultation with others) This section is mandatory due to legal requirements Healthcare Standard 13 This paper is based upon the expert external review by Professor Duerden (1), which also takes account of the review and report by Public Health Wales (2) into the outbreak of Clostridium difficile infection at Ysbyty Glan Clwyd in early The Board and its Committees may reject papers/proposals that do not appear to satisfy the equality duty. See

2 Equality Impact Assessment (EqIA) 1. Has EqIA screening been undertaken? No 2. Has a full EqIA been undertaken? No 3.Please state how this paper supports the Strategic Equality Plan Objectives: 4.Please include a justification if no EqIA has been carried out: Recommendations: (e.g for Board approval or for noting) The Health Board is asked to: 1. Note Clostridium difficile infection rates, and the continued progress that is being made to achieve the recommendations in the Duerden report. 2. Note the number of deaths reported since September 2013 in patients who have had Clostridium difficile infection, consider the issues identified via the RCA process, and note the progress made in investigating the mortality issue highlighted previously at WMH. 3. Consider the monthly infection rates reported for MRSA bacteraemia and MSSA bacteraemia, noting the increase in MRSA bacteraemia, the gaps identified in MRSA policy and control, and the significant programme of work being put into place to address this. 4. Review the information provided on antimicrobial prescribing, including the key actions required by CPGs. 5. Note the national reduction targets set for MRSA bacteraemia and Clostridium difficile infection, to be achieved by March Highlight any issues where further information or assurance is required at this time by the Board. Author(s) Presented by Mrs T Cooper, Assistant Director of Nursing - Infection Prevention & Mr B Owen, Clinical Director of Pharmacy Medicines Management (Interim Lead Antimicrobial Pharmacist) Mrs A Hopkins, Executive Director of Nursing & Midwifery Date of report 07 th January 2014 Date of meeting 23 rd January 2014 Disclosure: Betsi Cadwaladr University Health Board is the operational name of Betsi Cadwaladr University Local Health Board

3 Betsi Cadwaladr University Health Board Health Board paper Date: 23 rd January 2014 Subject: Update on the Prevention and Control of Healthcare Associated Infections in the Betsi Cadwaladr University Health Board Summary Introduction: BCUHB is committed to reducing preventable infections to the absolute minimum. We will do this by achieving excellent standards of infection prevention practice. This is the right thing to do for our population, and is the standard of care our staff want to deliver. This paper provides the Board with: An overview of progress on infection prevention, including progress in reducing Clostridium difficile infection (CDI). A briefing on the work programme to improve antimicrobial prescribing across BCUHB, and the actions necessary to achieve required outcomes. Information on new national targets for infection reduction. Increasing The Pace of Improvement: Focus on Key Practice Standards The Health Board is committed to increasing the pace of improvement and the speed of reduction of healthcare-associated infection (HCAI). Learning from the HCAI reduction programme in England shows that focus on a number of key practice standards is essential to achieve this. In early December, BCUHB issued 10 key standards for the reduction of both Clostridium difficile infection and MRSA. These standards are being implemented in all wards and departments, and have been included in the written objectives for CPGs. These key standards include clear expectation of the minimum practice standards to be achieved, and cover hand hygiene, cleanliness, training compliance and care bundle compliance. Work is in progress to ensure the care metrics system can be used for routine monitoring of compliance with the key standards. Monitoring will be via CPG governance arrangements, and Local Infection Prevention & Control Groups. Dashboard reporting of these standards to the Strategic Infection Prevention Group and Quality & Safety Committee is also being developed. The currently available summary data on these key standards is presented here: Key Standard BCUHB Compliance 1. Hand Hygiene compliance 96.17% 2. Commode audit compliance 95.66% 3. Isolation audit compliance To be collated via care metrics Page 1

4 4. PVC care bundle compliance 80.59% 5. Urinary catheter care bundle 90.82% 6. Bare below the elbows To be collated via care metrics 7. Cleanliness: domestic 94% 8. Cleanliness: nursing 89% 9. Cleanliness: risk assessment of estates issues 10. IPC Mandatory Training 33% This is a new requirement, and summary monitoring is being worked on at present Cleanliness Achieving a clean, safe environment is essential to inspire confidence in our patients and visitors, and to assist in the prevention of infection. Review of standards has confirmed that BCUHB can do more to consistently meet minimum national cleaning standards. A major programme has commenced to address the issues identified, including standardisation of products and methods based on evidence of effectiveness, review of cleaning frequencies and cleaning responsibilities, action to routinely achieve minimum national standards, and implementation of a robust monitoring framework and reporting of standards. As an initial step, routine cleaning using Actichlor plus has been implemented. This is a detergent-chlorine product, and published evidence shows it can help in reducing the number of cases of Clostridium difficile infection, and also help with Norovirus control. Cleanliness has been included in the 10 key standards, to ensure focus on this issue at clinical level. This programme is being led by the Operational Estates Department and an action plan is currently in development. The Strategic Healthcare Cleanliness Group will drive forward the action plan, and ensure sufficient pace is injected to deliver the improvements needed. More detailed information on the cleanliness work programme, and cleanliness standards will be provided in the next report to Board. MRSA Prevention Actions Welsh Government guidance requires that there should be routine MRSA screening prior to or on admission for all renal, cardiothoracic, vascular, intensive care and orthopaedic patients as a minimum. In addition, screening should be in place for other patients based upon a clinical risk assessment. Currently BCUHB does not consistently screen all of these groups. A significant programme of work on MRSA prevention is commencing, which will include: Development and implementation of an MRSA policy, to take account of all areas of BCUHB Page 2

5 Review to confirm the number of patients who will require screening to fully comply with Welsh Government policy Confirmation the laboratory system can handle the volume of screening specimens that will be required for full compliance with Welsh Government guidance Agreement with Pharmacy on the prescription and supply of decolonisation products (products used to eradicate carriage of MRSA) Acceptance that implementation of this programme will result in costpressures re: screening costs and decolonisation costs A major programme of education to support policy implementation, as this will require a significant change in clinical practice across all areas of BCUHB Audit and monitoring once the programme rolls out, to ensure it becomes embedded, and to identify areas where additional support and education is required. Given the scale of the work required, this will take time to fully implement. As a first step, work will be progressed with adult critical care units, in order to ensure best-practice measures are in place for this group of patients. Work on policy development has also commenced. Norovirus Control BCUHB continues to see outbreaks of Norovirus, most notably at WMH. Initial review of Norovirus control has been performed. This has identified that the rigour with which outbreak control measures are implemented could be improved. An action plan is in place to address this, which includes strengthening the BCU policy, additional focus on cleaning, and greater discipline in the implementation of contact precautions on outbreak wards. The initial impact appears to be positive, with no diarrhoea and vomiting outbreaks reported across the Health Board for the past 2 weeks (as at 9 th January 2013). Progress With Recommendations In The Duerden Report (1): Since the last meeting of the Board, progress has been made on a range of issues, including: Management (p16) The job description, person specification and job plan for the Lead Infection Prevention & Control Doctor has been approved by the Royal College of Pathologists, and the advert is now live on NHS jobs. The interview date is set for 24 th January Review of the interim arrangement for the Lead Antimicrobial Pharmacist has commenced, in order to determine the most suitable long-term model for BCUHB. Role of Site Management and Clinical Programme Groups (p17) CPGs have been issued with a set of clear and consistent objectives to ensure a focus on quality improvement, which include the 10 key standards for Clostridium difficile and MRSA reduction. Page 3

6 Staffing and Function of Local ICTs (p18) The Executive Team has approved the preferred option for the restructure of the Infection Prevention Team. Work to implement this structure has commenced. In the interim, additional temporary recruitment has been progressed for a period of 6 months to support the nursing team. PHW is also supporting BCUHB by seconding of one of their experienced Infection Prevention Nurses to support the team. Antimicrobial Stewardship (p18) The Board-wide launch of the Secondary Care Antimicrobial Prescribing Policy for adults took place on European Antibiotic Awareness day, 18 th November The Primary Care Antimicrobial Policy is to be ratified by March For the four months ending Oct 2013, there was a 6.53% reduction in antibiotic prescribed items in primary care compared to the same four months in A national and regional campaign is planned from April 2014 to raise awareness of the harm caused by unnecessary antibiotic usage. The Antimicrobial Audit and Improvement tool has been ratified by the Strategic Infection Prevention Group and is being rolled out within CPGs. This will provide monthly monitoring of compliance. Death Certification (p20) The 2 nd workshop to further develop and strengthen the Clostridium difficile infection care pathway has been held. The existing care pathway remains in use, with compliance monitored weekly, and reviewed at local site-based Infection Prevention & Control Meetings. Root Cause Analysis (p21) RCA is in place for all Clostridium difficile-related deaths, and for severe cases at YG and WMH sites. The next step is to roll this out to severe cases at YGC. A robust system to ensure action plans are completed is being implemented. A monthly HCAI Lessons Learned summary is being implemented from January 2014 to ensure shared learning across BCUHB Policy and Practice Final amendments are being made to the draft policy review programme, to ensure it includes all policies listed in the newly-launched Code of Practice. Communications The BCU communications team have met with the Assistant Director of Nursing, to agree in principle a plan for a wide-ranging communications campaign on infection prevention and control, aimed at staff, patients and the public. It is proposed to involve a variety of groups who represent patients and the public in this work. Page 4

7 Antimicrobial Stewardship BCU has been identified as an outlier for antibiotic prescribing in comparison with the rest of Wales. There is also considerable variation in prescribing across different geographical areas within our Health Board. This report seeks to provide an update of the current position and recommendations for further actions to ensure standardised antibiotic prescribing across the Health Board. There is considerable historic variation in volume of antibiotic prescribing in primary care across BCU, with Denbighshire, Gwynedd and Ynys Mon all having considerably higher prescribing rates than the rest of Wales. As with the secondary care data this could be due to more patients with infection or indicate over-diagnosis and treatment. However, for the four months ending October 2013, there was a 6.53% reduction in prescribed items and 8.63% reduction in spend on antimicrobials compared to the same four months in Gwynedd and Anglesey observed a 50% reduction in the use of Cephalosporin, Quinolone and Coamoxiclav prescribing during the same time period. These are the antibiotics which have specific concern with Clostridium difficile infection and the areas are now comparable to other North Wales counties. An all-wales survey of antimicrobial prescribing practices is performed annually, and BCUHB routinely participates. Results of the 2013 survey which took place in November are not yet available, and will be reported to Board once they are received. Key results from the 2012 survey are summarised below, and support the need for the programme of work to improve antimicrobial stewardship in secondary care. Secondary care total antibiotic usage 2012 There is almost a two-fold variation in total antibiotic prescribing from hospital K (Ysbyty Gwynedd) and hospital H (Wrexham Maelor). Ysbyty Glan Clwyd is hospital L. High usage of antibiotics without significant variations in case mix can imply a larger proportion of that usage might be unnecessary, exposing patients to unnecessary risk, including the development of health care associated infections. Page 5

8 Secondary care antibiotic prescribing rates Antibacterial prescribing rates K H J A L P F C N M E D S B R G T The three acute sites within BCUHB sit at the higher end of percentage prescribing rates compared to the rest of Wales, with each site having a rising rate. A higher prescribing rate could be due to more patients with infection on the day of the study or be an indicator of over-diagnosis of infection or prolonged courses of therapy such that patients are exposed to unnecessary drug. Antimicrobial Pharmacist Ward Round Data Measurement The Antimicrobial Pharmacists perform regular ward rounds to review antimicrobial prescribing. Response to feedback, particularly when provided on an individual consultant level, has been largely positive and data has been used to support the revalidation and appraisal process for consultants and their teams. Globally, the data suggest similar issues with antimicrobial prescribing and review processes to those highlighted in the All Wales reports. Progress and Recommendations A major cultural shift with regards to the prescribing and review processes for antibiotics is ongoing within the Health Board. The Hospital Antimicrobial Prescribing Policy sets out expectations and standards for CPGs and provides a tool for measurement of compliance with the support of Clinical Audit. A business case is being submitted to Welsh Government in time for the 2014/15 Modernising Pharmacy Capital Programme, to replace and modernise the pharmacy IT system and roll out electronic prescribing. This will antimicrobial e-prescribing and monitoring. directly support Page 6

9 Consultant antimicrobial champions are to be identified in each CPG for each site. Primary Care antimicrobial guidelines are at the final stages of approval. A plan is being developed for a high-profile launch campaign for these guidelines, similar to that recently staged across our hospitals, to ensure the use of the new guidelines in primary care. Action is being taken to ensure antimicrobial prescribing is a core feature in the 2014/15 GP Prescribing Incentive Scheme & Local Enhanced Service. BCUHB is working with Welsh Government to establish a national and regional campaign from April 2014 to raise public awareness of the harm associated with unnecessary antibiotics. Impact of Actions To Date: Clostridium difficile Infection The number of new cases of Clostridium difficile infection across the Health Board continues to show an overall reduction trend, and the rise in numbers in September-October has been halted. A total of 34 cases were reported across all primary and secondary care NHS locations within the Health Board in December The charts below are provided by the Welsh Healthcare Associated Infection Programme. The total number of patients positive for Clostridium difficile across all primary and secondary care NHS locations within the Health Board is reported, with the rate calculated by using all admissions to Health Board inpatient facilities as a denominator. Monthly Numbers of Clostridium difficile (aged 2 and over) in BCUHB Number of Clostridium difficile (aged 2 and over) Monthly numbers of Clostridium difficile (aged 2 and over) diagnosed in Betsi Cadwaladr University Health Board, for the period Apr 10 to Dec 13 Apr-10 May-10 Jun-10 Jul-10 Aug-10 Sep-10 Oct-10 Nov-10 Dec-10 Jan-11 Feb-11 Mar-11 Apr-11 May-11 Jun-11 Jul-11 Aug-11 Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 May-13 Jun-13 Jul-13 Aug-13 Sep-13 Oct-13 Nov-13 Dec-13 Number of Clostridium difficile (aged 2 and over) Mth/Yr Trend Page 7

10 Monthly Rates of Clostridium difficile (aged 2 and over) in BCUHB, per 1000 Hospital Admissions Clostridium difficile (aged 2 and over)/1,000 admissions Monthly rates of Clostridium difficile (aged 2 and over) diagnosed in Betsi Cadwaladr University Health Board per 1,000 hospital admissions, for the period Apr 10 to Dec 13 Apr-10 May-10 Jun-10 Jul-10 Aug-10 Sep-10 Oct-10 Nov-10 Dec-10 Jan-11 Feb-11 Mar-11 Apr-11 May-11 Jun-11 Jul-11 Aug-11 Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 May-13 Jun-13 Jul-13 Aug-13 Sep-13 Oct-13 Nov-13 Dec-13 Mth/Yr Clostridium difficile (aged 2 and over)/1,000 hospital admssions Trend In line with the decrease in case numbers, the rate within BCUHB has dropped to 4.39 cases per 1000 hospital admissions in December The published all-wales rate for October is 3.00 cases per 1000 hospital admissions, meaning BCUHB remains as a high outlier for this infection. Clostridium difficile by Site This data is reported as the number of patients positive from within each acute hospital, and rates are obtained by using the number of acute admissions to the same hospital as a denominator. Note that site-based data does not take account of patients who are positive in other locations outside the acute sites. YGC: Monthly Numbers of Clostridium difficile (aged 2 and over Number of Clostridium difficile (aged 2 and over) Monthly numbers of Clostridium difficile (aged 2 and over) diagnosed in Glan Clwyd General Hospital, for the period Apr 10 to Dec 13 Apr-10 May-10 Jun-10 Jul-10 Aug-10 Sep-10 Oct-10 Nov-10 Dec-10 Jan-11 Feb-11 Mar-11 Apr-11 May-11 Jun-11 Jul-11 Aug-11 Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 May-13 Jun-13 Jul-13 Aug-13 Sep-13 Oct-13 Nov-13 Dec-13 Mth/Yr Number of Clostridium difficile (aged 2 and over) Trend YG: Monthly Numbers of Clostridium difficile (aged 2 and over) Number of Clostridium difficile (aged 2 and over) Monthly numbers of Clostridium difficile (aged 2 and over) diagnosed in Ysbyty Gwynedd, for the period Apr 10 to Dec 13 Apr-10 May-10 Jun-10 Jul-10 Aug-10 Sep-10 Oct-10 Nov-10 Dec-10 Jan-11 Feb-11 Mar-11 Apr-11 May-11 Jun-11 Jul-11 Aug-11 Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 May-13 Jun-13 Jul-13 Aug-13 Sep-13 Oct-13 Nov-13 Dec-13 Mth/Yr Number of Clostridium difficile (aged 2 and over) Trend Page 8

11 WMH: Monthly Numbers of Clostridium difficile (aged 2 and over) Number of Clostridium difficile (aged 2 and over) Monthly numbers of Clostridium difficile (aged 2 and over) diagnosed in Wrexham Maelor Hospital, for the period Apr 10 to Dec 13 Apr-10 May-10 Jun-10 Jul-10 Aug-10 Sep-10 Oct-10 Nov-10 Dec-10 Jan-11 Feb-11 Mar-11 Apr-11 May-11 Jun-11 Jul-11 Aug-11 Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 May-13 Jun-13 Jul-13 Aug-13 Sep-13 Oct-13 Nov-13 Dec-13 Number of Clostridium difficile (aged 2 and over) Mth/Yr Trend Comparison of acute site numbers and rates in December 2013: Site Number of Cases Rate per 1000 hospital admissions WMH YGC YG Not from acute sites 12 No rate calculated Deaths related to Clostridium difficile The number of deaths in patients who have Clostridium difficile infection continues to be very closely monitored. Deaths with CDI Listed on Death Certificate Apr May June July Aug Sept Oct Nov Dec YG/West YGC/Central WMH/East Total Deaths The number of patients with Clostridium difficile infection listed on part 1 of the death certificate (indicating a direct cause of death) was 11, and the number listed on part 2 (indicating it was a contributory factor) was 11. Root cause analysis on the care of these patients has identified a number of issues, including: Some delays in isolating patients with symptoms, or poor compliance with isolation practices The need to send repeat specimens if patients have a negative sample but diarrhoea continues in the absence of alternative diagnosis Cleanliness standards in some areas, and some staff unclear about who is responsible for cleaning certain items Patients previously positive for Clostridium difficile and re-admitted with symptoms; treatment not in line with guidelines for recurrence The process for receiving information and patient history on repatriation of patients from a specialty centre is under review, to ensure significant infection-related information is clearly communicated Page 9

12 Each RCA has an action plan developed, and an assurance process to confirm these are robustly implemented with all actions being completed is currently being put into place. An HCAI Lessons Learned Summary is being implemented, with effect from January 2014, to ensure that the lessons identified from RCAs are disseminated widely on a monthly basis. Report from Public Health Wales on Clostridium difficile Across BCUHB At the last meeting of the Board, the findings from the further report by Public Health Wales into the epidemiology of Clostridium difficile infection across BCUHB was discussed. The finding of concern was that in WMH, the proportion of total deaths and deaths within 30 days of Clostridium difficile infection was almost twice as high as in the other two hospitals. The action plan drawn up to investigate this finding has been progressed by the investigation team, which includes representation from PHW. To date the following has been confirmed: Audit data shows that there is no major issue with the sending of specimens for testing. This excludes lack of specimens as a cause. Detailed laboratory analysis (ribotyping) of the first 20 cases does not show the presence of an aggressive ribotype, or evidence of widespread cross-infection. This appears to exclude the presence of a specific Clostridium difficile ribotype as the cause. Ribotyping of the remaining cases is being carried out at present. Casenote review has been completed, and the report is awaited from PHW. Laboratory cross-checking of test results between the laboratories at WMH and YGC has been completed, and there is concordance between laboratories on the results. This excludes laboratory procedures as a possible cause. The second meeting of the investigation team identified some additional investigative actions based on the preliminary findings, and these are now being put into place. Routine quarterly analysis of 30-day all-cause mortality for patients who have Clostridium difficile infection has been agreed with PHW, and this is next due in January 2014, for the period to the end December Update on Other Healthcare-Associated Infections: Bloodstream infections caused by Meticillin-resistant Staphylococcus aureus (MRSA), and Meticillin-sensitive Staphylococcus aureus (MSSA) are also monitored as part of the national programme in Wales. The charts below are provided by the Welsh Healthcare Associated Infection Programme. For BCUHB data, the total number of patients positive across all primary and secondary care NHS locations within the Health Board is reported, with the Page 10

13 rate calculated by using all admissions to Health Board in-patient facilities as a denominator. MRSA Bacteraemia Monthly Rates of MRSA Bacteraemia in BCUHB, per 1000 Hospital Admissions MRSA bacteraemia/1,000 admissions Monthly rates of MRSA bacteraemia diagnosed in Betsi Cadwaladr University Health Board per 1,000 hospital admissions, for the period Apr 10 to Dec 13 Apr-10 May-10 Jun-10 Jul-10 Aug-10 Sep-10 Oct-10 Nov-10 Dec-10 Jan-11 Feb-11 Mar-11 Apr-11 May-11 Jun-11 Jul-11 Aug-11 Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 May-13 Jun-13 Jul-13 Aug-13 Sep-13 Oct-13 Nov-13 Dec-13 MRSA bacteraemia/1,000 hospital admssions Mth/Yr Trend MRSA Bacteraemia: Comparison of BCUHB to All-Wales Data 2013 Q3 Number of Cases Rate per 1000 hospital admissions BCUHB All-Wales BCUHB All-Wales October November December MRSA Bacteraemia by Site This data is reported as the number of patients positive from within each acute hospital, and rates are obtained by using the number of acute admissions to the same hospital as a denominator. Note that site-based data does not take account of patients who are positive in other locations outside the acute sites. MRSA: Comparison of Numbers and Rates in December 2013: Site Number of Cases Rate per 1000 hospital admissions WMH YGC YG Not from acute sites 0 Rate is not calculated BCUHB remains a high outlier in Wales for MRSA bacteraemia. The actions that are being put into place regarding policy, screening, and other preventative actions will be fundamental in addressing this. Page 11

14 MSSA Bacteraemia For BCUHB data, the total number of patients positive across all primary and secondary care NHS locations within the Health Board is reported, with the rate calculated by using all admissions to Health Board in-patient facilities as a denominator. Monthly Rates of MSSA Bacteraemia in BCUHB, per 1000 Hospital Admissions MSSA bacteraemia/1,000 admissions Monthly rates of MSSA bacteraemia diagnosed in Betsi Cadwaladr University Health Board per 1,000 hospital admissions, for the period Apr 10 to Dec 13 Apr-10 May-10 Jun-10 Jul-10 Aug-10 Sep-10 Oct-10 Nov-10 Dec-10 Jan-11 Feb-11 Mar-11 Apr-11 May-11 Jun-11 Jul-11 Aug-11 Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 May-13 Jun-13 Jul-13 Aug-13 Sep-13 Oct-13 Nov-13 Dec-13 MSSA bacteraemia/1,000 hospital admssions Mth/Yr Trend MSSA Bacteraemia: Comparison of BCUHB to All-Wales Data 2013 Q3 Number of Cases Rate per 1000 hospital admissions BCUHB All-Wales BCUHB All-Wales October November December MSSA Bacteraemia by Site This data is reported as the number of patients positive from within each acute hospital, and rates are obtained by using the number of acute admissions to the same hospital as a denominator. Note that site-based data does not take account of patients who are positive in other locations outside the acute sites. MSSA: Comparison of Numbers and Rates in December 2013: Site Number of Cases Rate per 1000 hospital admissions WMH YGC YG Not from acute sites 0 Rate not calculated This data shows that overall BCUHB compares well with the all-wales rate for MSSA bacteraemia, providing an indicator of safe care. However, there continues to be variability between and within sites month-on-month which Page 12

15 requires continued monitoring. Initial review of the cases reported at WMH indicates that a number of them were probably acquired in the community, and further investigation is in progress in relation to these cases. New National Targets for HCAI reduction The Executive Team and specialist leads attended an HCAI event run by Welsh Government in December A number of initiatives were announced at this event including new national targets and a large-scale change initiative. Large-scale change programme Welsh government are advocating adoption of a large-scale change methodology for health-economy wide action to reduce HCAI. This model has been used successfully elsewhere, and BCUHB is keen to progress this approach. Initial discussions have been held with experts who may be able to support BCUHB progress this. National Targets for HCAI Reduction All Health Boards have been issued with new targets for reduction of Clostridium difficile infection and MRSA bacteraemia. For BCUHB this means that by March 2015, there must be no more than: 18 cases of Clostridium difficile infection per month (216 per year) 1.5 cases of MRSA bacteraemia per month (18 per year) Reduction trajectories are currently being finalised to ensure close monitoring of progress towards those targets. These will also be calculated by site so that it is clear what performance is expected at local level within BCUHB. Next Steps: The improvement action plan will continue to be progressed, with specific emphasis on: Achievement of the 10 key standards will continue to be driven forward as a priority in clinical areas. Learning from the improved RCA process that is in place will start to be shared across BCUHB, and action plans will be monitored to provide assurance that everything has been done. The work programme to drive up standards of cleanliness will continue, and more detailed performance information will be included in the next report to Board. The major focus on antimicrobial prescribing will continue, including progression of the actions identified in this paper, and an update will be included in the next report to Board. Page 13

16 Trajectories for the new national targets will be finalised and implemented, with monthly monitoring put into place. The opportunity to implement a large-scale change programme across the area of BCUHB will be actively progressed. The improvement action plan will continue to be monitored monthly to ensure sufficient progress is being made against all areas of work. Any lack of progress is escalated rapidly to the Director of Nursing and Midwifery and Medical Director for executive level action. Focus throughout BCUHB will remain on infection prevention and control, to ensure patients are protected from avoidable harm and receive safe care. References: 1. Review of Governance Arrangements, Structures and Systems for the Prevention and Control of Healthcare-Associated Infections in the Betsi Cadwaladr University Health Board. Professor B. Duerden. August 2013 Page 14

Quality and Safety Committee. Prevention and Control of Healthcare Acquired Infections performance to February 2012

Quality and Safety Committee. Prevention and Control of Healthcare Acquired Infections performance to February 2012 Betsi Cadwaladr University Health Board Committee Paper 05.04.12 Item QS12/37.5 Name of Committee: Subject: Summary or Issues of Significance National / Local Objectives Addressed: Legislation or Healthcare

More information

Prevention and control of healthcare-associated infections

Prevention and control of healthcare-associated infections Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process

More information

Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36

Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36 Healthcare-associated infections: prevention ention and control Public health guideline Published: 11 November 2011 nice.org.uk/guidance/ph36 NICE 2017. All rights reserved. Subject to Notice of rights

More information

Together for Health A Delivery Plan for the Critically Ill

Together for Health A Delivery Plan for the Critically Ill Together for Health A Delivery Plan for the Critically Ill 2013-2016 March 2015 Approved at CPG Board 25 th March 2015 1. BACKGROUND AND CONTEXT Together for Health a Delivery Plan for the Critically Ill

More information

The safety of every patient we care for is our number one priority

The safety of every patient we care for is our number one priority HUMBER NHS FOUNDATION TRUST INFECTION PREVENTION AND CONTROL STRATEGY 2015-2017 1. Introduction Healthcare associated infections (HCAI) continue to be a major cause of patient harm and although nationally

More information

TRUST BOARD. Date of Meeting: 05/10/2010

TRUST BOARD. Date of Meeting: 05/10/2010 TRUST BOARD Date of Meeting: 05//20 Enclosure: 7 Agenda Item No: 8.3 Title of Report: Interim Report for Infection Prevention and Control 20-2011 Aims: To inform the Board of the work of the Trust in controlling

More information

Influence of Patient Flow on Quality Care

Influence of Patient Flow on Quality Care Influence of Patient Flow on Quality Care Patients Waiting on Trolleys for an Inpatient Bed Patients who are Medically Fit to be discharged and cared for at Home with Support or in a Nursing Home or District

More information

HEALTHCARE ASSOCIATED INFECTION PREVENTION AND CONTROL REPORT JUNE 2016

HEALTHCARE ASSOCIATED INFECTION PREVENTION AND CONTROL REPORT JUNE 2016 Appendix--75 Borders NHS Board HEALTHCARE ASSOCIATED INFECTION PREVENTION AND CONTROL REPORT JUNE Aim The purpose of this paper is to update Board members of the current status of Healthcare Associated

More information

Report by Professor Brian I. Duerden CBE, BSc, MD, FRCPath, FRCPE Emeritus Professor of Medical Microbiology, Cardiff University

Report by Professor Brian I. Duerden CBE, BSc, MD, FRCPath, FRCPE Emeritus Professor of Medical Microbiology, Cardiff University Review of Governance Arrangements, Structures and Systems for the Prevention and Control of Healthcare Associated Infections in the BetsiCadwaladrUniversity Health Board Report by Professor Brian I. Duerden

More information

NHS Highland Infection Prevention & Control Annual Work Plan End of Year

NHS Highland Infection Prevention & Control Annual Work Plan End of Year NHS Highland Board 5 April Item 5.7 NHS Highland & Control Annual Work Plan End of Year Update for COIC Prepared by Catherine Stokoe and Jonty Mills (as of 01/03/) Objective Activity Time Scale Lead Officer

More information

Influence of Patient Flow on Quality Care

Influence of Patient Flow on Quality Care Influence of Patient Flow on Quality Care Patients Waiting on Trolleys for an Inpatient Bed Patients who are Medically Fit to be discharged and cared for at Home with Support or in a Nursing Home or District

More information

Bwrdd Iechyd Prifysgol Betsi Cadwaladr University Health Board

Bwrdd Iechyd Prifysgol Betsi Cadwaladr University Health Board Thursday 25 th November 2010 Liberty Stadium / Optic Technium Bwrdd Iechyd Prifysgol Betsi Cadwaladr University Health Board Betsi Cadwaladr University Health Board Ysbyty Glan Clwyd Ysbyty Gwynedd Ysbyty

More information

REPORT SUMMARY SHEET

REPORT SUMMARY SHEET Quality care for you, with you REPORT SUMMARY SHEET Meeting: Date: Title: Lead Director: Corporate Objective: Purpose: High level context: Trust Board 27 th October 2016 Infection Prevention and Control

More information

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 22 FEBRUARY 2012

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 22 FEBRUARY 2012 SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS C 22 FEBRUARY 2012 Subject: Supporting : Author: Status (see footnote): Update on the Clostridium difficile (C.diff)

More information

Standard 22 Managing Risk and Health & Safety

Standard 22 Managing Risk and Health & Safety Betsi Cadwaladr University Health Board Board Paper 6.5.14 Item 14/84 Subject: Summary or Issues of Significance Corporate Risk Register This paper provides an overview of the current risks on the Corporate

More information

REPORT SUMMARY SHEET

REPORT SUMMARY SHEET Quality care for you, with you REPORT SUMMARY SHEET Meeting: Date: Title: Lead Director: Corporate Objective: Purpose: High level context: Trust Board 29 th September 2016 Infection Prevention and Control

More information

Quality and Safety Committee

Quality and Safety Committee Betsi Cadwaladr University Health Board Committee Paper 13.6.13 Item QS13/112.1 Name of Committee: Subject: Summary or Issues of Significance Quality and Safety Committee Endoscopy action plan Situation:.This

More information

WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT

WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT 2006-2007 Author(s) Gill Harris, Director of Infection Prevention and Control EXECUTIVE

More information

Board of Director s Meeting

Board of Director s Meeting Board of Director s Meeting Meeting Date: 15 November 212 Agenda item: 6.1 Title: Purpose: Summary: Recommendation: Author: Presented by: QUALITY AND PATIENT SAFETY ASSURANCE COMMITTEE To provide an exception

More information

Infection Prevention and Control Strategy (NHSCT/11/379)

Infection Prevention and Control Strategy (NHSCT/11/379) Infection Prevention and Control Strategy (NHSCT/11/379) September 2010 September 2010 Contents Page No. 1. Foreword 1 2. Introduction 2-3 3. Key Principles 4-5 4. Objectives 6-13 5. Organisational Arrangements

More information

Infection Prevention and Control Annual Report 2012/13

Infection Prevention and Control Annual Report 2012/13 Infection Prevention and Control Annual Report 2012/13 Infection Prevention and Control Annual Report 2012/13 1 Contents 1. Executive Overview 2. Key Achievements 3. Infection Prevention and Control Team

More information

Healthcare associated infections across the health and social care community

Healthcare associated infections across the health and social care community Healthcare associated infections across the health and social care community Professor Brian Duerden CBE Inspector of Microbiology and Infection Control, Department of Health, London Infection is different..it

More information

Betsi Cadwaladr University Health Board. Quality and Safety Committee Item QS12/60.4. Subject:

Betsi Cadwaladr University Health Board. Quality and Safety Committee Item QS12/60.4. Subject: Betsi Cadwaladr University Health Board Quality and Safety Committee14.6.12 Item QS12/60.4 Subject: Summary or Issues of Significance Wales Ombudsman s Report Section 16 aggregated review: Serious Concerns

More information

MRSA: National developments, Progress, Challenges and Targets

MRSA: National developments, Progress, Challenges and Targets MRSA: National developments, Progress, Challenges and Targets Professor Brian Duerden Inspector of Microbiology and Infection Control, Department of Health, London The MRSA challenge - 2007 Bacteraemia

More information

To Dip or Not To Dip

To Dip or Not To Dip To Dip or Not To Dip a patient centred approach to improve the management of UTI in the Care Home environment FIS 30 th November 2017 #ToDipOrNotToDip #FIS17 Elizabeth Beech on behalf of colleagues National

More information

HCAI Local implementation team action plan

HCAI Local implementation team action plan HCAI Local implementation team action plan Item Type Report Authors New Governance HCAI Group Publisher New Governance HCAI Group Download date 16/09/2018 18:12:09 Link to Item http://hdl.handle.net/10147/110814

More information

abc INFECTION CONTROL STRATEGY

abc INFECTION CONTROL STRATEGY abc INFECTION CONTROL STRATEGY 1. INTRODUCTION East and North Hertfordshire NHS Trust (ENHT) considers the reduction of Healthcare Associated infections (HCAI) a key component of patient safety systems

More information

Infection Prevention. & Control. Report

Infection Prevention. & Control. Report Infection Prevention & Control Report April 2012 March 2013 Author Joanne Raper, Infection Prevention & Control Nurse Manager Page 1 of 10 1.0 Purpose of the Paper The purpose of this report is to provide

More information

Open and Honest Care in your Local Hospital

Open and Honest Care in your Local Hospital Open and Honest Care in your Local Hospital Report for: Royal Wolverhampton NHS Trust January 2016 The Open and Honest Care: Driving Improvement Programme aims to support organisations to become more transparent

More information

Radiology CPG Annual Report for Quality, Safety and Experience Sub-Committee- April 2015

Radiology CPG Annual Report for Quality, Safety and Experience Sub-Committee- April 2015 Radiology CPG Annual Report for Quality, Safety and Experience Sub-Committee- April 2015 1. Purpose of report To provide assurance to the QSE sub-committee of the Radiology CPG s commitment to quality,

More information

Using mortality data to improve the quality and safety of patient care December 2015

Using mortality data to improve the quality and safety of patient care December 2015 Using mortality data to improve the quality and safety of patient care December 2015 Version Date Published Notes 12.0 18/12/2015 12 th publication 11.0 18/09/2015 11 th publication 10.0 19/06//2015 10

More information

Workforce and Organisational Development Committee. Minutes of the meeting held on in the Board Room, Ysbyty Gwynedd and via videoconference

Workforce and Organisational Development Committee. Minutes of the meeting held on in the Board Room, Ysbyty Gwynedd and via videoconference Workforce and Organisational Development Committee Minutes of the meeting held on 13.3.14 in the Board Room, Ysbyty Gwynedd and via videoconference Present: Dr P Higson Ms J Dean Dr C Tillson Mr K McDonogh

More information

West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan [Updated 19/3/13] Item 37/13

West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan [Updated 19/3/13] Item 37/13 Introduction purpose: West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan 2012-2013 [Updated 19/3/13] Item 37/13 This action plan has been developed by West Hertfordshire

More information

INFECTION CONTROL SURVEILLANCE POLICY

INFECTION CONTROL SURVEILLANCE POLICY INFECTION CONTROL SURVEILLANCE POLICY Version: 3 Ratified by: Date ratified: July 2016 Title of originator/author: Title of responsible committee/group: Senior Managers Operational Group Head of Infection

More information

Infection prevention and control

Infection prevention and control Infection prevention and control Annual Report 2016/17 National Infection Prevention and Control Strategic Management Team Dee Sissons Executive Director of Nursing, Marie Curie Director, Infection Prevention

More information

SOUTHAMPTON UNIVERSITY HOSPITALS NHS TRUST Trust Key Performance Indicators May Regular report to Trust Board

SOUTHAMPTON UNIVERSITY HOSPITALS NHS TRUST Trust Key Performance Indicators May Regular report to Trust Board SOUTHAMPTON UNIVERSITY HOSPITALS NHS TRUST Trust Key Performance Indicators May 20 Report to: Trust Board July 20 Report from: Sponsoring Executive: Aim of Report/Principle Topic: Review History to date:

More information

CLOSTRIDIUM DIFFICILE ACTION PLAN

CLOSTRIDIUM DIFFICILE ACTION PLAN CLOSTRIDIUM DIFFICILE ACTION PLAN Action plan to address the rise in cases of Clostridium difficile (C.diff) at Sheffield Teaching Hospitals NHS Foundation Trust ACTION KEY MILESTONES PERSON RESPONSIBLE

More information

Quality Improvement Strategy

Quality Improvement Strategy Quality Improvement Strategy The Board s Strategic Implementation Plan 2014 2017 Approved at Betsi Cadwaladr University Health Board on Following approval at the Board, there are some minor amendments

More information

COVENTRY AND RUGBY CLINICAL COMMISSIONING GROUP

COVENTRY AND RUGBY CLINICAL COMMISSIONING GROUP COVENTRY AND RUGBY CLINICAL COMMISSIONING GROUP Report To: Governing Body 11 September 2013 Report From: Title of Report: Purpose of the Report: Jacqueline Barnes, Executive Nurse The Nursing and Quality

More information

Revised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014

Revised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014 Background Revised East Kent Hospitals University NHS Foundation Trust C. difficile Recovery / Action Plan April 2014 The C.difficile objective for EKHUFT in 2013 2014 was 29 cases and in April 2013, the

More information

NHS LANARKSHIRE QUALITY DASHBOARD Board Report October 2011 (Data available as at end August 2011)

NHS LANARKSHIRE QUALITY DASHBOARD Board Report October 2011 (Data available as at end August 2011) NHS LANARKSHIRE QUALITY DASHBOARD Board Report October 2011 (Data available as at end August 2011) INTRODUCTION This paper provides a monthly quality dashboard for NHS Lanarkshire. This is in line with

More information

For further information please contact: Health Information and Quality Authority

For further information please contact: Health Information and Quality Authority For further information please contact: Infection Prevention and Control 13-15 The Mall Beacon Court Bracken Road Sandyford Dublin 18 Phone: +353 (0)1 293 1140 Email: ipc@hiqa.ie URL www.hiqa.ie Guide

More information

Report by Liz McClurg, Infection Control Manager on behalf of Heidi May, Board Nurse Director & Executive Lead, Infection Prevention & Control

Report by Liz McClurg, Infection Control Manager on behalf of Heidi May, Board Nurse Director & Executive Lead, Infection Prevention & Control INFECTION PREVENTION & CONTROL ANNUAL WORK PLAN (2013 2014) Highland NHS Board 4 June 2013 Item 5.5(c) Report by Liz McClurg, Infection Control Manager on behalf of Heidi May, Board Nurse Director & Executive

More information

The prevention, management and control of Healthcare Associated Infections (HCAI) in hospitals (ROCR-LITE/08/014/FT6)

The prevention, management and control of Healthcare Associated Infections (HCAI) in hospitals (ROCR-LITE/08/014/FT6) NATIONAL AUDIT OFFICE STUDY The prevention, management and control of Healthcare Associated Infections (HCAI) in hospitals (ROCR-LITE/08/014/FT6) National Audit Office study The prevention, management

More information

Antimicrobial stewardship in Scotland: quality improvement agenda

Antimicrobial stewardship in Scotland: quality improvement agenda Antimicrobial stewardship in Scotland: quality improvement agenda Dr Jacqueline Sneddon Project Lead Scottish Antimicrobial Prescribing Group Background Scottish Antimicrobial Prescribing Group (SAPG)

More information

SUMMARY OF INDICATOR CHANGES FOR VERSION 3 INTELLIGENT MONITORING REPORTS Acute and Specialist NHS Trusts 23 June Final Draft, Subject to Change

SUMMARY OF INDICATOR CHANGES FOR VERSION 3 INTELLIGENT MONITORING REPORTS Acute and Specialist NHS Trusts 23 June Final Draft, Subject to Change Never Event incidence Yes: 01 May 2013-30 Apr 2014 Incidence of Clostridium difficile (C.difficile) Incidence of Meticillin-resistant Staphylococcus aureus (MRSA) Dr Foster Intelligence: Mortality rates

More information

Nottingham University Hospitals Emergency Department Quality Issues Related to Performance

Nottingham University Hospitals Emergency Department Quality Issues Related to Performance RCCG/GB/14/123 Nottingham University Hospitals Emergency Department Quality Issues Related to Performance Introduction NUH have failed to meet the 95% 4 hour wait standard for a number of consecutive months.

More information

Inspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust

Inspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust Inspecting Informing Improving Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust December 2008 Outcome of inspection for: Hospital(s) visited: West Hertfordshire Hospitals NHS Trust

More information

Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery

Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery Issue Action Risk to Year-end trajectory for C difficile infections is 29 cases. Week commencing 09.12.13 - Performance

More information

NHS performance statistics

NHS performance statistics NHS performance statistics Published: 8 th February 218 Geography: England Official Statistics This monthly release aims to provide users with an overview of NHS performance statistics in key areas. Official

More information

Checklists for Preventing and Controlling

Checklists for Preventing and Controlling Checklists for Preventing and Controlling Clostridium difficile Infection (CDI) This document has been developed to specifically assist senior management and all ward staff to take appropriate actions,

More information

Progress Report on C.Diff Action Plan

Progress Report on C.Diff Action Plan NHS GREATER GLASGOW AND CLYDE NHS Board Meeting 16 December 2008 Paper No. 08/55 Board Medical Director Progress Report on C.Diff Action Plan Recommendation The NHS Board is asked to receive this further

More information

NHS Performance Statistics

NHS Performance Statistics NHS Performance Statistics Published: 8 th March 218 Geography: England Official Statistics This monthly release aims to provide users with an overview of NHS performance statistics in key areas. Official

More information

Provincial Surveillance

Provincial Surveillance Provincial Surveillance Provincial Surveillance 2011/12 Launched first provincial surveillance protocols Establishment of provincial data entry & start of formal surveillance reports Partnership with AB

More information

Learning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care.

Learning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care. Learning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care. Associated Policies Being Open and Duty of Candour policy CG10 Clinical incident / near-miss

More information

Reducing the risk of healthcare associated infection

Reducing the risk of healthcare associated infection i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can

More information

The prevention and control of infections North Cumbria University Hospitals NHS Trust

The prevention and control of infections North Cumbria University Hospitals NHS Trust The prevention and control of infections North Cumbria University Hospitals NHS Trust Region: North West Provider s code: RNL Type of organisation: Acute trust Type of inspection: Enhanced Sites we visited:

More information

THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST HEALTHCARE ASSOCIATED INFECTIONS (HCAI)

THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST HEALTHCARE ASSOCIATED INFECTIONS (HCAI) THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST HEALTHCARE ASSOCIATED INFECTIONS (HCAI) Agenda item A4(i) EXECUTIVE SUMMARY The paper highlights the increasingly challenging HCAI targets for the

More information

Board Meeting 01/12/16 Open Session Item 10. Performance and Quality Report to the Board December 2016

Board Meeting 01/12/16 Open Session Item 10. Performance and Quality Report to the Board December 2016 Board Meeting 01/12/16 Open Session Item 10 Performance and Quality Report to the Board ember Introduction This report summarises key areas of performance which includes, but is not limited to, Local Delivery

More information

BOARD CLINICAL GOVERNANCE & QUALITY UPDATE MARCH 2013

BOARD CLINICAL GOVERNANCE & QUALITY UPDATE MARCH 2013 Borders NHS Board BOARD CLINICAL GOVERNANCE & QUALITY UPDATE MARCH 2013 Aim The aim of this report is to provide the Board with an overview of progress in the areas of: Patient Safety Person Centred Health

More information

Ruth McCarthy, Associate Director Clinical Governance/IP&C

Ruth McCarthy, Associate Director Clinical Governance/IP&C Trust Board Meeting: 25 April 28 Title: Executive Summary: Items for discussion: Clinical Governance/Infection Prevention and Control Report - April 28 The Clinical Governance Report April 28 comprises:

More information

RESPIRATORY HEALTH DELIVERY PLAN

RESPIRATORY HEALTH DELIVERY PLAN RESPIRATORY HEALTH DELIVERY PLAN 1. BACKGROUND AND CONTEXT Together for Health a Respiratory Health Delivery Plan was published in April 2014 and provides a framework for action by Health Boards and NHS

More information

Ensuring quality outcomes

Ensuring quality outcomes Annual integrated report 20 64 Ensuring quality outcomes Over the past five years we have built an integrated quality management system that drives quality improvement across all Netcare divisions. More

More information

Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield Teaching Hospitals NHS Foundation Trust Sheffield Teaching Hospitals NHS Foundation Trust @seamlesssurgery Seamless Surgery Team Sheffield Teaching Hospitals NHS Foundation Trust July 2017 PROUD TO MAKE A DIFFERENCE PROUD TO MAKE A DIFFERENCE

More information

Staffordshire and Stoke on Trent Partnership Trust Infection Prevention and Control team. Director of Infection Prevention and Control Annual Report

Staffordshire and Stoke on Trent Partnership Trust Infection Prevention and Control team. Director of Infection Prevention and Control Annual Report Staffordshire and Stoke on Trent Partnership Trust Infection Prevention and Control team Director of Infection Prevention and Control Annual Report April 215 to March 216 1 Executive Summary The Health

More information

Establishing an infection control accreditation programme to control infection

Establishing an infection control accreditation programme to control infection International Journal of Infection Control www.ijic.info ISSN 1996-9783 Establishing an infection control accreditation programme to control infection Julie Parker Sheffield Teaching Hospitals NHS Foundation

More information

Combating Healthcare Associated Infections in the NHS. Inspector of Microbiology and Infection Control, Department of Health, London

Combating Healthcare Associated Infections in the NHS. Inspector of Microbiology and Infection Control, Department of Health, London Combating Healthcare Associated Infections in the NHS Professor Brian Duerden Inspector of Microbiology and Infection Control, Department of Health, London 2007 -The challenge of HCAI MRSA bacteraemia

More information

Infection Control. Annual Report 2014 / 15

Infection Control. Annual Report 2014 / 15 Infection Control Annual Report 2014 / 15 July 2015 Report 1. Introduction and Background 1.1 The Trust supports the principle that healthcare acquired infections should be prevented wherever possible

More information

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015

Prevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Prevention and Control of Infection in Care Homes Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Content for today Importance of IPAC -refresher IPAC audits in

More information

CDI case checklist and standard assessment tool. Liz Stokle, AMRS and HCAI Programme Lead, Nurse Epidemiologist, PHE

CDI case checklist and standard assessment tool. Liz Stokle, AMRS and HCAI Programme Lead, Nurse Epidemiologist, PHE CDI case checklist and standard assessment tool Liz Stokle, AMRS and HCAI Programme Lead, Nurse Epidemiologist, PHE Background to work December 2013, Working Group set up to address concerns about: whether

More information

Director of Infection Prevention and Control

Director of Infection Prevention and Control Director of Infection Prevention and Control 2016-17 2 Contents Page 1. Executive Summary 4 2. Infection prevention and control arrangements 5 3. Healthcare Associated Infection Performance 6 3.1. Mandatory

More information

Integrated Performance Report

Integrated Performance Report Integrated Performance Report M06 September 2014 Presented by: Paul Bostock (Chief Operating Officer) Des Holden (Medical Director) Fiona Allsop (Chief Nurse) Paul Simpson (Chief Financial Officer) An

More information

Infection Prevention and Sepsis Team Annual Report

Infection Prevention and Sepsis Team Annual Report 2016/17 Infection Prevention and Sepsis Team Annual Report We will be a leading centre in healthcare driven by excellence in patient experience, research, teaching and education. Helen Bucior Infection

More information

NHS LANARKSHIRE QUALITY DASHBOARD Board Report June 2011 (Data available as at end April 2011)

NHS LANARKSHIRE QUALITY DASHBOARD Board Report June 2011 (Data available as at end April 2011) NHS LANARKSHIRE QUALITY DASHBOARD Board Report June 2011 (Data available as at end April 2011) INTRODUCTION This paper provides a monthly quality dashboard for NHS Lanarkshire. This is in line with the

More information

Reducing the risk of healthcare associated infection

Reducing the risk of healthcare associated infection i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can

More information

Infection Prevention and Control

Infection Prevention and Control Infection Prevention and Control Annual Report 2010/11 Presented by: Director of Infection Prevention and Control Written and Compiled by: Lead Nurse, Infection Prevention and Control Contributors: Hotel

More information

Infection Prevention and Control Annual Report Produced by: The Director of Infection Prevention and Control

Infection Prevention and Control Annual Report Produced by: The Director of Infection Prevention and Control Infection Prevention and Control Annual Report 2009 Produced by: The Director of Infection Prevention and Control Reviewing the period: January 2009 - December 2009 Approved by Infection Control Committee:

More information

INVESTIGATION UNDER SECTION 17 OF THE WELSH LANGUAGE ACT Betsi Cadwaladr University Local Health Board

INVESTIGATION UNDER SECTION 17 OF THE WELSH LANGUAGE ACT Betsi Cadwaladr University Local Health Board INVESTIGATION UNDER SECTION 17 OF THE WELSH LANGUAGE ACT 1993 Betsi Cadwaladr University Local Health Board Background The main aim of the Welsh Language Commissioner, an independent role created in accordance

More information

Tom Walsh Infection Control Manager May 2008 ANNUAL INFECTION CONTROL REPORT 2007/08

Tom Walsh Infection Control Manager May 2008 ANNUAL INFECTION CONTROL REPORT 2007/08 Tom Walsh Infection Control Manager May 2008 ANNUAL INFECTION CONTROL REPORT 2007/08 CONTENTS 1. INTRODUCTION... 1 2. ACCOUNTABILITY ARRANGEMENTS FOR PREVENTION & CONTROL OF INFECTION WITHIN NHSGGC...

More information

Reducing Mortality and Harm in ABMU Local Health Board

Reducing Mortality and Harm in ABMU Local Health Board 10 th June 2011 Reducing Mortality and Harm in ABMU Local Health Board Insert name of presentation on Master Slide Programme Driver Diagram Aims/Outcome Measure Reduce Mortality Reduce RAMI to

More information

Mandatory Surveillance of Healthcare Associated Infections Report 2006

Mandatory Surveillance of Healthcare Associated Infections Report 2006 Mandatory Surveillance of Healthcare Associated Infections Report 2006 Contents 1. Introduction...2 2. Key Points...3 3. Results of the fifth year of mandatory surveillance of MRSA bacteraemia, including

More information

Board Briefing. Board Briefing of Nursing and Midwifery Staffing Levels. Date of Briefing January 2018 (December 2017 data)

Board Briefing. Board Briefing of Nursing and Midwifery Staffing Levels. Date of Briefing January 2018 (December 2017 data) Board Briefing Board Briefing of Nursing and Midwifery Staffing Levels Date of Briefing January 2018 (December 2017 data) This paper is for: Sponsor: Chief Nurse- Dame Eileen Sills (DBE) Decision Author:

More information

Safeguarding Children, Young People & Vulnerable Adults Sub-Committee Annual Report

Safeguarding Children, Young People & Vulnerable Adults Sub-Committee Annual Report Betsi Cadwaladr University Health Board Committee 03.01.13 Item QS13/017.2.1 Subject: Summary or Issues of Significance Safeguarding Children, Young People & Vulnerable Adults Sub-Committee Annual Report

More information

The challenge for today - best practice, better outcomes and safer healthcare

The challenge for today - best practice, better outcomes and safer healthcare The challenge for today - best practice, better outcomes and safer healthcare A practical guide to improving practice & monitoring compliance against the National Quality Standard for Healthcare associated

More information

INFECTION PREVENTION & CONTROL ANNUAL REPORT 2016 / 2017

INFECTION PREVENTION & CONTROL ANNUAL REPORT 2016 / 2017 INFECTION PREVENTION & CONTROL ANNUAL REPORT 1 2016 / 2017 AUTHOR Mustafa Ahmed Governance Improvement Manager DIRECTOR OF INFECTION PREVENTION & CONTROL Garry Marsh Executive Director of Patient Services

More information

MENTAL HEALTH CLINICAL PROGRAMME GROUP. MENTAL HEALTH ACT 1983 ANNUAL REPORT 1 October March MHA Report.Final/10.4.

MENTAL HEALTH CLINICAL PROGRAMME GROUP. MENTAL HEALTH ACT 1983 ANNUAL REPORT 1 October March MHA Report.Final/10.4. MENTAL HEALTH CLINICAL PROGRAMME GROUP MENTAL HEALTH ACT 1983 ANNUAL REPORT 1 October 21 31 March 212 MHA Report.Final/1.4.12 1 MENTAL HEALTH CLINICAL PROGRAMME GROUP MENTAL HEALTH ACT 1983 ANNUAL REPORT

More information

Infection Prevention and Control (IPC) Annual Programme 20010/11

Infection Prevention and Control (IPC) Annual Programme 20010/11 Infection Prevention and Control (IPC) Annual Programme 20010/11 1. Introduction The Code of Practice for the Prevention and Control of Healthcare Associated Infections (DH, 2009) otherwise known as the

More information

NHS performance statistics

NHS performance statistics NHS performance statistics Published: 14 th December 217 Geography: England Official Statistics This monthly release aims to provide users with an overview of NHS performance statistics in key areas. Official

More information

A Successful Health Visitor Retention Strategy - Walsall Healthcare NHS Trust

A Successful Health Visitor Retention Strategy - Walsall Healthcare NHS Trust A Successful Health Visitor Retention Strategy - Walsall Healthcare NHS Trust Health Visiting Local Picture Population of approx 21,000 under 5s 10 Health Visitor Teams across the borough New model of

More information

BOARD MEETING. Document is for: (indicate with an x) Assurance x Information Decision. Executive Summary

BOARD MEETING. Document is for: (indicate with an x) Assurance x Information Decision. Executive Summary Document Title: Presenter: Author: Contact details for further information: BOARD MEETING Review of Pressure Ulcer Prevalence across DCHS services March June 2012 Kath Henderson, Chief Nurse Michelle O

More information

Infection Prevention & Control Annual Report 2011/2012

Infection Prevention & Control Annual Report 2011/2012 Infection Prevention & Control Annual Report 2011/2012 Board of Directors Approval date: 1 November 2012 Infection Prevention & Control Committee Submission date: 1 August 2012 Position at 31 March 2012

More information

The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England

The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England Report by the Comptroller and Auditor General The Management and Control of Hospital Acquired Infection in Acute NHS Trusts in England Ordered by the House of Commons to be printed 14 February 2000 LONDON:

More information

Safer Nursing and Midwifery Staffing Recommendation The Board is asked to: NOTE the report

Safer Nursing and Midwifery Staffing Recommendation The Board is asked to: NOTE the report To: Board of Directors Date of Meeting: 26 th July 20 Title Safer Nursing and Midwifery Staffing Responsible Executive Director Nicola Ranger, Chief Nurse Prepared by Helen O Dell, Deputy Chief Nurse Workforce

More information

Integrated Performance Report

Integrated Performance Report Integrated Performance Report M12 March 2015 Presented by: Paul Bostock (Chief Operating Officer) Des Holden (Medical Director) Fiona Alsop (Chief Nurse) Paul Simpson (Chief Financial Officer) An Associated

More information

SPSP Medicines. Prepared by: NHS Ayrshire and Arran

SPSP Medicines. Prepared by: NHS Ayrshire and Arran SPSP Medicines Prepared by: NHS Ayrshire and Arran Medication Reconciliation: Story so far MR happening in primary care, acute adult, paediatrics and mental health Started in acute then mental health,

More information

Board of Directors Infection Prevention and Control Report. Dr Claire Thomas, DIPC

Board of Directors Infection Prevention and Control Report. Dr Claire Thomas, DIPC Board of Directors 25 November Report to: Title: Author: Sponsoring Director Purpose: Decision Sought: Board of Directors Infection Prevention and Control Report Dr Claire Thomas, DIPC Donna Green 6 monthly

More information

Infection Prevention and Control Annual Report 1 st April st March 2013

Infection Prevention and Control Annual Report 1 st April st March 2013 Infection Prevention and Control Annual Report 1 st April 2012-31 st March 2013 Patient friendly version Edited by: Fighting Infection Together (FIT) group Table of Contents Section: Page: 1 Introduction

More information

Protocol for the Prevention and Management of Clostridium difficile.

Protocol for the Prevention and Management of Clostridium difficile. Protocol for the Prevention and Management of Clostridium difficile. Policy Profile Policy Reference: Clinical care protocol 14. App D Clin 2.0 Version: Version 2.1 Author: Selma Mehdi, Lead Nurse Infection

More information

Staphylococcus aureus bacteraemia in Australian public hospitals Australian hospital statistics

Staphylococcus aureus bacteraemia in Australian public hospitals Australian hospital statistics Staphylococcus aureus bacteraemia in Australian public hospitals 2013 14 Australian hospital statistics Staphylococcus aureus bacteraemia (SAB) in Australian public hospitals 2013 14 SAB is a serious bloodstream

More information

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 21 MARCH 2012

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 21 MARCH 2012 C SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 21 MARCH 2012 Subject: C.difficile Action Plan 2012/2013 Supporting Director: Professor Hilary Chapman, Chief Nurse/Chief

More information